Picture biomindz Mainz Biomed LSG Colorectal Cancer Screening 650x100px

Person › Details

Olaf Klinger (Symrise AG)

Klinger, Olaf (Symrise 201902 CFO)

	Organisation	Symrise AG
	Group	Symrise (Group)
	Product	food ingredient
	Source	Symrise AG. (2/8/19). "Press Release: Symrise Successfully Completes Capital Increase. Strong Investor Demand – 5.614 Million New Shares Placed – Gross Proceeds amount of € 400 Million [Not for US, CA, AU or JP]".

Record changed: 2022-04-26

Picture biomindz TRON LSG Mainz Translation Cancer Immunotherapy 650x200px

More documents for Olaf Klinger

[1] Symrise AG. (4/14/22). "Press Release: Symrise Successfully Places €750 million ESG-linked Promissory Loan Notes". Holzminden....
[2] Symrise AG. (5/27/20). "Press Release: Symrise Opens Production Site in China"....
[3] Symrise AG. (2/8/19). "Press Release: Symrise Successfully Completes Capital Increase. Strong Investor Demand – 5.614 Million New Shares Placed – Gross Proceeds amount of € 400 Million [Not for US, CA, AU or JP]"....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to [email protected] and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)